LENZ
  
  
      
        LENZ Therapeutics
      
      
        
          LENZ
        
        
      
    
  
          LENZ
        
        
      113 hedge funds and large institutions have $725M invested in LENZ Therapeutics in 2025 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 53 increasing their positions, 15 reducing their positions, and 16 closing their positions.
New
  Increased
  Maintained
  Reduced
  Closed
  more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
25% more funds holding in top 10
Funds holding in top 10: 4 → 5 (+1)
11.34% more ownership
Funds ownership: 76.52% → 87.85% (+11%)
8% more funds holding
Funds holding: 105 → 113 (+8)
    
      Holders
    
  
  
    
      
        
      
        113
      
    
      
    
  
    
      Holding in Top 10
    
  
  
    
      
        
      
        5
      
    
      
    
  
    
      Calls
    
  
  
    
      
        
      
        $11.5M
      
    
      
    
  
    
      Puts
    
  
  
    
      
        
      
        $305K
      
    
      
    
  
Top Buyers
| 1 | +$17.1M | |
| 2 | +$11.6M | |
| 3 | +$10.1M | |
| 4 | 
    SVCM
   
      Saturn V Capital Management
     
      
        Austin,
      
      
        Texas
      
     | +$10M | 
| 5 | 
      Invesco
     
      
        Atlanta,
      
      
        Georgia
      
     | +$7.82M | 
Top Sellers
| 1 | -$8.57M | |
| 2 | -$6.86M | |
| 3 | -$5.37M | |
| 4 | 
      Manulife (Manufacturers Life Insurance)
     
      
        Canada,
      
      
        Ontario, Canada
      
     | -$1.09M | 
| 5 | 
    BP
   
      BBR Partners
     
      
      
        New York
      
     | -$1.03M |